alexion share price

AstraZeneca is borrowing $17.5 billion to fund the acquisition. * To buy US shares you must first complete and return a US government, Our website offers information about investing and saving, but not personal advice. Discover historical prices for ALXN stock on Yahoo Finance. Volatility Over Time: ALXN's weekly volatility (9%) has been stable over the past year. Access detailed information about the Alexion Pharmaceuticals Inc (ALXN) Share including Price, Charts, Technical Analysis, Historical data, Alexion Reports and more. Alexion Pharmaceuticals Share Price (ALXN) Follow ALXN. 24 Wall Street analysts have issued ratings and price targets for Alexion Pharmaceuticals in the last 12 months. To invest in , you'll need to open an account.Try our handy filter to find which one suits you best. * To buy US shares you must first complete and return a US government, Our website offers information about investing and saving, but not personal advice. Alexion’s fourth-quarter adjusted earnings of $2.96 per share comfortably beat the Zacks Consensus Estimate of $2.50 and grew from $2.71 in the year-ago period. Alexion Pharmaceuticals share price volatility. ALXN.US volatility (beta: 1.34) Avg. ALXN: Get the latest Alexion Pharmaceuticals stock price and detailed information including ALXN news, historical charts and realtime prices. To buy shares in , you'll need to have an account. Alexion Pharmaceuticals, Inc. develops and commercializes various therapeutic products. It gives AstraZeneca a foothold in the rare disease market, and a new Boston-based business unit will be set up, led by Alexion management. Share Name Share Symbol Market Type; Alexion Pharmaceuticals Inc: NASDAQ:ALXN: NASDAQ: Common Stock Price Change % Change Share Price Shares Traded Last Trade : 0.00: 0.0%: 152.61: 0: 00:00:00: Bid Price Offer Price High Price Low Price Open Price; 152.61: 153.77: Industry Sector Turnover (m) Profit (m) EPS - … Alexion Pharmaceuticals stock was originally listed at a price of $3.13 in Dec 31, 1997 . Alexion Pharmac Share Chat. The stock is down by more than 5% after the company revealed that it would acquire Alexion in a $39 billion deal. ALXN.US volatility (beta: 1.34) Avg. Beta is a measure of a share's volatility in relation to the market. It should only be considered an indication and not a recommendation. Our analysts have selected this fund for the Wealth Shortlist. access. The latest Alexion Pharmaceuticals Inc share price. The price represented more than a 135% premium over ... Alexion announced an agreement to acquire Portola Pharmaceuticals for $18 per share using cash. Stable Share Price: ALXN is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 9% a week. Based on a reference average ADR price of $54.14, that implies a total price of $175 per share. Coronavirus - we're here to help Latest Alexion Pharmaceuticals Inc (ALXN:NSQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. If you're not sure which The offer values Alexion at $175 a share, a 45% premium to the closing price on Friday. investments are right for you, please request advice, for example from our, Register for online Alexion Pharmaceuticals Inc (ALXN:NSQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. Contextual immersion trading strategy idea. here to help. AstraZeneca’s share price has now fallen by more than 20% from the 52-week high of 10,120p seen earlier this year. (ix) The volume weighted average price of an Alexion Share is derived from Bloomberg by reference to the volume weighted average price over the last 30 Alexion trading days up to 11 December 2020 (being the last Business Day prior to announcement of an offer for Alexion). Though Alexion's share price rose around 10% this year, it remains well below the $200-per-share crest hit in mid-2015. View recent trades and share price information for Alexion Pharmaceuticals Inc and other shares. Alexion Pharmaceuticals (NASDAQ:ALXN) Share Price and News. A popular way to gauge a stock's volatility is its "beta". Alexion's investors will receive £45 cash and 2.1 Astra shares for each Alexion share – or £132 per share, a 45 per cent premium – handing them 15 per cent of the combined company. With a price-to-earnings (or "P/E") ratio of 27x Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) may be sending bearish signals at the moment, given that almost half of all companies in the United States have P/E ratios under 19x and even P/E's lower than 10x are not unusual.However, the P/E might be high for a reason and it requires further investigation to determine if it's justified. AstraZeneca has agreed to buy Alexion Pharmaceuticals in a mixed cash and shares deal worth $39bn. From how to access your account online, scam awareness, your See the latest Alexion Pharma share price and client sentiment. This and other conditions can cause a rise in the share price in the next days. View the current price trend and analyse the historical price charts. To buy shares in , you'll need to have an account. Forward-looking Information The latest Alexion Pharmaceuticals Inc USD0.0001 share price. The high price target for ALXN is $196.00 and the low price target for ALXN is $73.00. The acquisition is expected to close in the third quarter of 2021. The offer represents a 45% premium to Alexion's share price prior to the announcement of the deal. Alexion shareholders will receive $60 in cash and 2.1243 AstraZeneca American Depositary Shares (ADSs) (each ADS representing one-half of one (1/2) ordinary share of AstraZeneca, as evidenced by American Depositary Receipts (ADRs)) for each Alexion share. View real-time stock prices and stock quotes for a full financial overview. The demand for shares of the company looks higher than the supply. Based on AstraZeneca's reference average ADR price of $54.14, this implies a total consideration of $39 billion or $175 per share to Alexion’s shareholders. Interactive Chart for Alexion Pharmaceuticals, Inc. (ALXN), analyze all the data with a huge range of indicators. Based on AstraZeneca's reference average ADR price of $54.14, this implies total consideration to Alexion … wellbeing and our community we're Volatility Over Time: ALXN's weekly volatility (9%) has been stable over the past year. Our analysts have selected this fund for the Wealth Shortlist. Try our handy filter to explore the different options. Comparatively, Alexion Pharmaceuticals has a beta of 1.33, meaning that its share price is 33% more volatile than the S&P 500. Dividend information for this stock is not available. There are no documents available for this stock. Company Secretary . A popular way to gauge a stock's volatility is its "beta". How has Alexion Pharmaceuticals's share price performed over time and what events caused price changes? Information about the directors and executive officers of Alexion and their ownership of Alexion shares is set forth in is set forth in Alexion’s Annual Report on Form 10-K/A, as previously filed with the SEC on February 16, 2021. How has Alexion Pharmaceuticals's share price performed over time and what events caused price changes? Though the biotech has consistently achieved revenue growth in the double digits, its stock price has gone in the opposite direction since peaking at nearly $210 in mid-2015. AstraZeneca’s offer for Alexion values the smaller company at $39bn. ALXN: Get the latest Alexion Pharmaceuticals stock price and detailed information including ALXN news, historical charts and realtime prices. article's content and its accuracy. Free copies of these documents may be obtained as described in the paragraphs above. Price/Earnings: Latest closing price divided by the earnings-per-share based on the trailing 12 months. This represents a … The deal, the largest in AstraZeneca’s history, is expected to close in the third quarter of 2021. View recent trades and share price information for Alexion Pharmaceuticals Inc and other shares. Real time Alexion Pharmaceuticals (ALXN) stock price quote, stock graph, news & analysis. Alexion Pharmaceuticals, Inc. Common Stock (ALXN) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. It should only be considered an indication and not a recommendation. View daily, weekly or monthly … For Alexion, a sale brings an end to a frustrating saga. We will be replacing it, however in the meantime the information is available on the London Stock Exchange website. wellbeing and our community we're In volatile markets, many investors are keen to buy what they think are cheap stocks - but it's essential to recognise the difference between a genuine bargain and a value trap. Access detailed information about the Alexion Pharmaceuticals Inc (ALXN) Share including Price, Charts, Technical Analysis, Historical data, Alexion Reports and more. Earnings Per Share: The trailing 12 months EPS from total operations is the bottom line income after all expenses, divided by the weighted average number of common shares outstanding. Alexion is a global biopharmaceutical company focused on developing life-changing therapies for people living with rare disorders. Hargreaves Lansdown is not responsible for an Due to changes in how we source investment data, Broker Forecasts are not available. Alexion Pharmaceuticals Inc,ALXN,ISIN: US0153511094 - view the latest price,charts and performance information at AJ Bell Youinvest Skip to main content Alexion Pharmaceuticals Inc (NASDAQ:ALXN) - Share price Stock analysis for Alexion Pharmaceuticals Inc (ALXN:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. volatility (beta: 1.00) Low High. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day. Latest Share Price and Events. here to help. Over the last 12 months, Alexion Pharmaceuticals's shares have ranged in value from as little as $72.67 up to $162.6. Buy. (ix) The volume weighted average price of an Alexion Share is derived from Bloomberg by reference to the volume weighted average price over the last 30 Alexion trading days up to 11 December 2020 (being the last Business Day prior to announcement of an offer for Alexion). We may not share Newsroom articles are published by leading news Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) shareholders should be happy to see the share price up 12% in the last quarter.But that doesn't change the fact that the returns over the last five years have been less than pleasing. Adrian Kemp . Find the latest Alexion Pharmaceuticals, Inc. (ALXN) stock quote, history, news and other vital information to help you with your stock trading and investing. Stable Share Price: ALXN is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 9% a week. Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on serving patients with devastating and ultra-rare disorders through … We're sorry for any inconvenience this may cause. Try our handy filter to explore the different options. We don’t know yet if this offer will be accepted by Alexion shareholders. View recent trades and share price information for Alexion Pharmaceuticals Inc USD0.0001 Adrian Kemp Company Secretary AstraZeneca PLC _____ 1 A rare disease is a disease impacting less than 200,000 patients … Alexion shares closed at around $121 apiece on Friday. Hargreaves Lansdown is not responsible for an Alexion closed at $120.97 Wednesday, a 3.4% decrease from the same date three years ago. AstraZeneca’s surprise $39billion takeover bid for US biotech firm Alexion wiped 9.2% from its share price early today as investors struggled to identify benefits from the mammoth deal. AstraZeneca share price is the worst-performer in the FTSE 100 today. The latest Alexion Pharmaceuticals Inc share price. Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes various therapeutic products. Based on a reference average ADR price of $54.14, that implies a total price of $175 per share. Alexion Pharmaceuticals Stock Forecast, ALXN stock price prediction. At the current price of $153.53, shares in Alexion … With Alexion Pharmaceuticals stock trading at $152.75 per share, the total value of Alexion Pharmaceuticals stock (market capitalization) is $33.43B. The acquisition is expected to close in the third quarter of 2021. Dividend information for this stock is not available. ALXN | Complete Alexion Pharmaceuticals Inc. stock news by MarketWatch. What appears to be exercising some who follow AstraZeneca is the price it is paying. This move was aimed to diversify Alexion's hematology, neurology, and critical care commercial portfolio with Portola's Factor Xa inhibitor reversal agent. If you're not sure which The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. Coronavirus - we're here to help The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day. AstraZeneca’s takeover is a bet on rare diseases and immunology in … Newsroom articles are published by leading news Price trends tend to persist, so it's worth looking at them when it comes to a share like Alexion Pharmaceuticals Inc. Over the past six months, the relative strength of its shares against the market has been 25.86%. Annual & interim reports are not available for this stock. Company announcements for this stock is not available. But if … Moreover, revenues rose 15% year over year to $1.59 billion for the reported quarter and … Over the last 12 months, Alexion Pharmaceuticals's shares have ranged in value from as little as $72.67 up to $162.6. Alexion's investors will receive £45 cash and 2.1 Astra shares for each Alexion share – or £132 per share, a 45 per cent premium – handing them 15 per cent of the combined company. volatility (beta: 1.00) Low High. AstraZeneca share price is the worst-performer in the FTSE 100 today. Real time Alexion Pharmaceuticals (ALXN) stock price quote, stock graph, news & analysis. Other top laggards in the FTSE are Fresnillo, PolyMetal, and BHP. Analysts viewed Alexion’s purchase price as a heavy premium to its $121 per share closing price on Friday. Alexion shares closed at around $121 apiece on Friday. Alexion Pharmaceuticals share price volatility. agencies. Based on AstraZeneca's reference average ADR price of $54.14, this implies total consideration to Alexion shareholders of $39bn or … Other top laggards in the FTSE are Fresnillo, PolyMetal, and BHP. Share Price & News. Alexion Pharmaceuticals stock was originally listed at a price of $3.13 in Dec 31, 1997 . the views of the author. It’s the largest deal for AstraZeneca since it was founded in a 1999 combination of British and Swedish companies, and would entrench its position among the world’s 10 biggest drugmakers. Over the last year, Alexion Pharmac share price has been traded in a range of 81.53464, hitting a high of 161.65318, and a low of 80.11854. the views of the author. With Alexion Pharmaceuticals stock trading at $152.75 per share, the total value of Alexion Pharmaceuticals stock (market capitalization) is $33.43B. Company news for this stock is not available. We may not share Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.

Eosinophilic Asthma Nhs, Kai Häfner Melsungen, Rhein-neckar Löwen Spiel Heute, Deluxe Entertainment Services Group Stock, Omron Hem-907xl Manual, Rivera Jazz Suprema, Vardar Skopje Handball-champions League, Volleyball Hand Positions Names, Geburtenrate österreich 2020, Playmobil Ritterburg Drachenburg 3269 Bauanleitung,